A patient with obesity and type 2 diabetes has a liver biopsy showing hepatic steatosis (fat accumulation) but no inflammation or fibrosis. Six years later a repeat biopsy shows hepatocyte ballooning, lobular inflammation, and early perisinusoidal fibrosis. What best explains this transition?
ATriglyceride accumulation alone was sufficient to cause fibrosis — fat in hepatocytes is directly toxic to the extracellular matrix
BLipotoxicity from saturated free fatty acids and their metabolites triggered oxidative stress, mitochondrial dysfunction, and inflammatory cytokine release — a 'second hit' that converted simple steatosis to NASH
CThe patient must have developed alcoholic liver disease in the interval — inflammation cannot arise in NAFLD without alcohol
DPortal hypertension from venous obstruction caused the inflammatory infiltrate
Simple steatosis is largely reversible and does not itself drive fibrosis. The transition to NASH requires a second set of injurious mechanisms: lipotoxic species (ceramides, diacylglycerols) impair mitochondrial function and generate reactive oxygen species; oxidative stress exceeds antioxidant defenses; Kupffer cells release TNF-α, IL-6, and IL-1β; together these activate hepatic stellate cells that deposit collagen. Fat accumulation alone is not sufficient — the lipotoxic cascade is the critical second hit.
Question 2 Multiple Choice
Which cell type is most directly responsible for collagen deposition and fibrosis progression in NASH?
AHepatocytes — when lipid-laden, they secrete collagen directly into the perisinusoidal space
BKupffer cells — they produce TGF-β which spontaneously polymerizes into collagen fibers
CHepatic stellate cells — activated by TGF-β and reactive oxygen species, they transform into myofibroblasts and deposit extracellular matrix collagen
DCholangiocytes — bile duct epithelial cells that remodel the matrix during cholestatic injury
Hepatic stellate cells are the fibrosis effectors. Normally quiescent and lipid-storing in the perisinusoidal space, they transform into activated myofibroblasts when stimulated by TGF-β, PDGF, and reactive oxygen species released from injured hepatocytes and activated Kupffer cells. Once activated, they deposit collagen in the characteristic perisinusoidal pattern of NASH. Sustained activation drives the fibrosis progression: perisinusoidal → bridging → cirrhosis.
Question 3 True / False
Simple hepatic steatosis (fat accumulation without inflammation) carries the same risk of progression to cirrhosis as NASH (steatohepatitis with fibrosis).
TTrue
FFalse
Answer: False
Most patients with simple steatosis never progress to NASH or cirrhosis. Progression requires the 'second hit' — lipotoxicity, oxidative stress, and immune activation that drives stellate cell activation and collagen deposition. Simple steatosis is largely reversible; NASH with established fibrosis carries meaningful risk of cirrhosis and hepatocellular carcinoma. Identifying which patients will progress is the central clinical challenge in NAFLD management.
Question 4 True / False
Weight loss of 7–10% of body weight can improve NAFLD histology and even reverse early fibrosis.
TTrue
FFalse
Answer: True
Weight loss directly addresses the metabolic dysfunction driving the first hit: it reduces hepatic free fatty acid delivery by improving adipose insulin sensitivity, lowers de novo lipogenesis, and reduces inflammatory cytokine production from visceral adipose tissue. Studies consistently show that 7–10% weight loss improves hepatic steatosis, reduces lobular inflammation, and can reverse early perisinusoidal fibrosis — making lifestyle intervention the primary treatment for NAFLD.
Question 5 Short Answer
What is the 'two-hit' model of NAFLD progression, and why is the second hit necessary for fibrosis to develop?
Think about your answer, then reveal below.
Model answer: The first hit is hepatic steatosis — triglyceride accumulation driven by insulin resistance, excess free fatty acid delivery, and upregulated de novo lipogenesis. Simple steatosis is largely reversible and does not cause fibrosis on its own. The second hit consists of lipotoxic injury from saturated free fatty acids and their metabolites (ceramides, diacylglycerols) that impair mitochondrial function, generate reactive oxygen species, and trigger inflammatory signaling. This oxidative and inflammatory milieu activates hepatic stellate cells via TGF-β, driving collagen deposition and fibrosis.
The two-hit framework explains why most people with fatty livers never develop cirrhosis — only those who also sustain sufficient lipotoxic stress progress. The second hit is not just 'more fat'; it is a qualitative change in the cellular environment from steatosis to active inflammation and stellate cell activation. The distinction also explains the therapeutic window: interventions that address the first hit (weight loss, insulin sensitization) can prevent or reverse NASH even after steatosis is established.